BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2700244)

  • 1. Prevention of infectious complications in immunocompromised patients. Part II: Selective decontamination.
    Mĕrka V; Bláha M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1989; 32(4):357-84. PubMed ID: 2700244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections.
    Edlund C; Nord CE
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():41-8; discussion 63-5. PubMed ID: 11051623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.
    Edlund C; Nord CE
    Scand J Infect Dis Suppl; 1988; 56():14-21. PubMed ID: 3074461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the oropharyngeal and gastrointestinal microflora by ciprofloxacin: microbiological and clinical consequences.
    Edlund C; Nord CE
    Scand J Infect Dis Suppl; 1989; 60():98-103. PubMed ID: 2667112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection prophylaxis in acute leukaemia patients: comparison of selective and total antimicrobial decontamination of the gastrointestinal tract.
    Bhaduri S; Kurrle E; Krieger D; Pflieger H; Arnold R; Kubanek B; Heimpel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):377-89. PubMed ID: 6182058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections in immunocompromised patients. II. Established therapy and its limitations.
    Periti P; Mazzei T
    Clin Ther; 1985; 8(1):100-17. PubMed ID: 3854579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli.
    Donskey CJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S62-9. PubMed ID: 16894517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.
    van Vliet MJ; Tissing WJ; Dun CA; Meessen NE; Kamps WA; de Bont ES; Harmsen HJ
    Clin Infect Dis; 2009 Jul; 49(2):262-70. PubMed ID: 19514856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a human donor flora for recontamination following antibiotic decontamination.
    Heidt PJ; van der Waaij D; Vossen JM; Hendriks WD
    Prog Food Nutr Sci; 1983; 7(3-4):53-63. PubMed ID: 6419281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems and results of selective decontamination in leukemia patients.
    Günther I; Brijmohan-Günther R; Kundt G; Kaben U; Teseler RM
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):197-204. PubMed ID: 3914742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective bowel decontamination].
    Szántó Z; Pulay I; Kotsis L; Dinka T
    Orv Hetil; 2006 Apr; 147(14):643-7. PubMed ID: 16711371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of gastrointestinal decontamination in the occurrence of endogenous infections.
    Ozawa A; Nagao T; Sawamura S; Ikigai H
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():465-78. PubMed ID: 6520974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total intestinal decontamination for prevention of infection in bone marrow transplantation.
    Funada H; Teshima H; Hattori K
    Jpn J Clin Oncol; 1983; 13 Suppl 1():111-26. PubMed ID: 6339774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selective gut decontamination in ventilated intensive therapy patients].
    Gründling M; Feyerherd F; Panzig B
    Anaesthesiol Reanim; 1993; 18(6):164-70. PubMed ID: 8297449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance as a consequence of antimicrobial prophylaxis in immunocompromised patients.
    Dejace P; Klastersky J
    Scand J Infect Dis Suppl; 1986; 49():165-71. PubMed ID: 3547622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antimicrobial therapy on bowel flora.
    Hooker KD; DiPiro JT
    Clin Pharm; 1988 Dec; 7(12):878-88. PubMed ID: 3061721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
    Klastersky J
    Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-infective drugs in the prevention and treatment of sepsis syndrome.
    Beam TR
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):275-93. PubMed ID: 7946188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.